Literature DB >> 23702337

Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.

Gladys N Honein-AbouHaidar1, Nancy N Baxter, Rahim Moineddin, David R Urbach, Linda Rabeneck, Arlene S Bierman.   

Abstract

BACKGROUND: Participation in screening tests for colorectal cancer (CRC) is generally low in Ontario, Canada. In addition, inequities in participation exist including lower participation among low-income individuals, males and individuals living in rural areas. In April 2008, Colon Cancer Check (CCC) program, the province-wide CRC screening program, was launched in Ontario. This study describes the trends and inequities in CRC screening participation three years before and three years after the CCC, and assesses the effect of the program on CRC screening participation, overall and among certain population groups.
METHODS: We used administrative data to identify cohorts of individuals eligible for CRC screening in fiscal years 2005-2011. We calculated the age-standardized percent of Fecal Occult Blood Test (FOBT) participation, large bowel endoscopy participation, and being 'up-to-date' with CRC screening tests.
RESULTS: From 2005 to 2011, FOBT participation increased from 7.6% to 14.8%, large bowel endoscopy participation from 3.4% to 5.7%, and 'up-to-date' with CRC screening from 27.2% to 41.3%. Before the launch of the CCC program, the quarterly increase in FOBT participation was 0.07% (p=0.19), increased immediately after the launch (1.8%, p<0.01), followed by a decline (-0.08%, p=0.08), returning to its pre-program increase rate. We noted a significant decrease in FOBT participation every summer (-0.44%, p<0.01). The CCC program had minimal effect on large bowel endoscopy participation. Before the launch of the CCC program, the quarterly increase in 'up-to-date' with CRC screening was 0.9% (p<0.01), increased immediately after the launch (2.5%, p=0.05), followed by a modest decline thereafter (-0.59%, p<0.02). From 2005 to 2011, recent residents living in low-income neighborhoods were consistently and significantly less likely to have a FOBT and be 'up-to-date' with CRC screening than long-term residents living in high-income neighborhoods (2.9-4.5%; 14.7-17.3% respectively). Pre-CCC inequities in CRC participation persisted after the launch of the program.
CONCLUSION: CRC testing was increasing in Ontario from 2005. An immediate increase in CRC testing, FOBT in particular, occurred after the launch of the CCC program, followed by a return to its pre-CCC increase rate thereafter. Future efforts are needed to improve screening participation and address inequities.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CCC; CIHI-DAD; CRC; Canadian Institute for Health Information Discharge Abstract Database; Colon Cancer Check; Equity in screening participation; FOBT; Fecal Occult Blood Test; Health services research; ICES; Institute for Clinical Evaluative Sciences; Mass screening utilization; OCR; OHIP; Ontario Cancer Registry database; Ontario Health Insurance Plan database; PCCF+; Postal Conversion File; Program evaluation; RPDB; Registered Persons Database; Secondary data analysis; colorectal cancer

Mesh:

Year:  2013        PMID: 23702337     DOI: 10.1016/j.canep.2013.04.007

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  21 in total

1.  Screening rates for colorectal cancer in Canada: a cross-sectional study.

Authors:  Harminder Singh; Charles N Bernstein; Jewel N Samadder; Rashid Ahmed
Journal:  CMAJ Open       Date:  2015-04-02

2.  Differences in colorectal cancer screening rates across income strata by levels of urbanization: results from the Canadian Community Health Survey (2013/2014).

Authors:  Jonathan Simkin; Gina Ogilvie; Brendan Hanley; Catherine Elliott
Journal:  Can J Public Health       Date:  2018-10-23

3.  Geographical variation and factors associated with colorectal cancer mortality in a universal health care system.

Authors:  Mahmoud Torabi; Christopher Green; Zoann Nugent; Salaheddin Mahmud; Alain Demers; Jane Griffith; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04

Review 4.  Interventions to reach underscreened populations: a narrative review for planning cancer screening initiatives.

Authors:  Mavis Jones; Brenda Ross; Alyssa Cloth; Laura Heller
Journal:  Int J Public Health       Date:  2015-02-25       Impact factor: 3.380

5.  Socioeconomic inequalities in colorectal cancer incidence in Canada: trends over two decades.

Authors:  Mohammad Hajizadeh; Marie Charles; Grace M Johnston; Robin Urquhart
Journal:  Cancer Causes Control       Date:  2021-11-15       Impact factor: 2.506

6.  Small-area variation in screening for cancer, glucose and cholesterol in Ontario: a cross-sectional study.

Authors:  Kimberly A Fernandes; Rinku Sutradhar; Cornelia M Borkhoff; Nancy Baxter; Aisha Lofters; Linda Rabeneck; Jill Tinmouth; Lawrence Paszat
Journal:  CMAJ Open       Date:  2015-10-29

7.  The validity of self-reported cancer screening history and the role of social disadvantage in Ontario, Canada.

Authors:  Aisha Lofters; Mandana Vahabi; Richard H Glazier
Journal:  BMC Public Health       Date:  2015-01-29       Impact factor: 3.295

8.  Evaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario.

Authors:  Gladys N Honein-AbouHaidar; Linda Rabeneck; Lawrence F Paszat; Rinku Sutradhar; Jill Tinmouth; Nancy N Baxter
Journal:  BMC Cancer       Date:  2014-07-25       Impact factor: 4.430

9.  A population-based study of the extent of colorectal cancer screening in men with HIV.

Authors:  Tony Antoniou; Nathaniel Jembere; Refik Saskin; Alexander Kopp; Richard H Glazier
Journal:  BMC Health Serv Res       Date:  2015-02-01       Impact factor: 2.655

10.  Benefits and barriers to participation in colorectal cancer screening: a protocol for a systematic review and synthesis of qualitative studies.

Authors:  Gladys N Honein-Abouhaidar; Monika Kastner; Vincent Vuong; Laure Perrier; Linda Rabeneck; Jill Tinmouth; Sharon Straus; Nancy N Baxter
Journal:  BMJ Open       Date:  2014-02-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.